U.S. markets closed
  • S&P Futures

    3,822.00
    +12.75 (+0.33%)
     
  • Dow Futures

    31,004.00
    +92.00 (+0.30%)
     
  • Nasdaq Futures

    12,971.50
    +60.50 (+0.47%)
     
  • Russell 2000 Futures

    2,213.50
    +14.30 (+0.65%)
     
  • Crude Oil

    62.27
    +0.77 (+1.25%)
     
  • Gold

    1,735.00
    +6.20 (+0.36%)
     
  • Silver

    26.78
    +0.34 (+1.29%)
     
  • EUR/USD

    1.2089
    -0.0097 (-0.80%)
     
  • 10-Yr Bond

    1.4600
    -0.0580 (-3.82%)
     
  • Vix

    27.95
    -0.94 (-3.25%)
     
  • GBP/USD

    1.3960
    -0.0052 (-0.37%)
     
  • USD/JPY

    106.5470
    +0.3170 (+0.30%)
     
  • BTC-USD

    45,817.34
    -822.12 (-1.76%)
     
  • CMC Crypto 200

    912.88
    -20.25 (-2.17%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    28,966.01
    -1,202.29 (-3.99%)
     

PerkinElmer Board Declares Quarterly Dividend

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock January 28, 2021. This dividend is payable on May 7, 2021 to all shareholders of record at the close of business on April 16, 2021.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.9 billion in 2019, has about 14,000 employees serving customers in 190 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210128005995/en/

Contacts

Investor Relations:
Bryan Kipp
+1-781-663-5583
bryan.kipp@perkinelmer.com

Media Relations:
Chet Murray
+1-781-663-5719
chet.murray@perkinelmer.com